©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Eyewire News: The Podcast
Eyewire Podcast Logo Outlined
Eyewire News: The Podcast

11.20.24

Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD

The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle.

View full description +

MORE EPISODES

01.07.26

Staar Terminates Merger with Alcon

12.31.25

2025 Year in Review - Part 2

12.24.25

2025 Year in Review - Part 1

12.17.25

Update on Reproxalap PDUFA Timing

12.10.25

New Glaucoma Technologies Advance in Clinical Development

12.03.25

Eylea HD Approved for RVO and Extended Dosing

11.26.25

Leaders Discuss Emerging Technologies in Glaucoma

11.18.25

Live Coverage of B+L Investor Day

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D
close-x